Tribulus Terrestris trials recruiting now

1 registration that name tribulus Terrestris as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 1 registration

Status

All 1 registrations

RecruitingNCT06260007

Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia

  • Phase 4
  • Herbarium Laboratorio Botanico Ltda
  • About 204 people
  • Started Jul 12, 2024

In plain words A Phase 4 study of tribulus Terrestris in male participants 25 to 60, run by Herbarium Laboratorio Botanico Ltda. It plans to enroll about 204 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists male participants 25 to 60. Conditions: Oligospermia.

  • - Male;
  • - Ages 25 and 60;
  • - Diagnosis of oligospermia;
  • - With sexual partner;

1 more inclusion criterion and the exclusion criteria are on the listing.

What it tests, as registered

Tribulus terrestris; Placebo

Registered summary

Efficacy and Safety of Products Based on Tribulus terrestris, L. in Men with Oligospermia. It is expected that the benefits of investigational products outweigh the risks that will be mitigated or carefully managed by the study team.

Where, as registered

No US site; Brazil (1).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.